Work

Organ Biomarker Responses in Patients with Light Chain Amyloidosis Treated with NEOD001 Are Independent of Previous Hematologic Response

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.647.647

Authors: Michaela Liedtke, Raymond L. Comenzo, Heather Landau, Vaishali Sanchorawala, Brendan M. Weiss, Jeffrey A. Zonder, Jackie Walling, Gene G. Kinney, Martin Koller, Dale B. Schenk, Spencer D. Guthrie, Enchi Liu, Morie A. Gertz

Institutions: Stanford Medicine, Stanford University, Tufts Medical Center, Memorial Sloan Kettering Cancer Center, Boston University, Boston Medical Center, Abramson Cancer Center, University of Pennsylvania, The Barbara Ann Karmanos Cancer Institute, Prothena (United States), Mayo Clinic

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4244370538

FWCI:

Cites:

Cited by: 1

Related to: 10